Скачать или смотреть RSV Vaccine for Older Adults: 92% Protection Against Severe Outcomes - What You Need to Know

Discover the groundbreaking effectiveness of the RSV vaccine for adults aged 60 and older. A recent real-world study published in Clinical Infectious Diseases reveals that the RSVpreF (Abrysvo) vaccine is 92% effective in preventing severe respiratory illness, including emergency department visits and hospitalizations. This video breaks down the key findings, including the vaccine's 95% effectiveness in those aged 75 and older, and compares its performance to other respiratory vaccines like SARS-CoV-2, influenza, and pneumococcal vaccines. Learn why the CDC recommends this vaccine for high-risk individuals and why its uptake remains low. Stay informed about the potential expansion of recommendations to adults aged 50–59. Protect yourself and your loved ones—watch now to understand the importance of the RSV vaccine!